# Gavin P. Dunn

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gavin-p-dunn/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,001 |
| Field | Immunotherapy and Immune Responses |
| h-index | 58 |
| i10-index | 118 |
| Last Known Institution | Brigham Young University |
| OpenAlex ID | https://openalex.org/A5076166380 |
| ORCID iD | https://orcid.org/0000-0001-9302-4834 |
| Works | 1,074 |

## Researcher papers

- [Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial](https://scholariq.org/papers/neoadjuvant-and-adjuvant-pembrolizumab-in-resectable-locally-advanced-human/)

## Researcher topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)
- [vaccines and immunoinformatics approaches](https://scholariq.org/topics/vaccines-and-immunoinformatics-approaches-2/)
- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Researcher university

- [Brigham Young University](https://scholariq.org/institutions/brigham-young-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.